Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
developed a novel hypoxia-activated combination nanomedicine that targets hypoxic tumors through hypoxia-sensitive block copolymers and photothermal/photodynamic therapy (PTT/PDT), efficiently delivering drugs and achieving synergistic anticancer effects of chemotherapy and PDT/PTT, completely eliminating advanced breast cancer, including hypoxic and metastatic tumors, stimulating a systemic antitumor immune response, and significantly improving survival rates, showing important clinical application potential [500]
This mix matches the natural composition of healthy skin
Together, we can prioritize our health and well-being.
Multiple paxillin binding sites regulate FAK function
Targets 24, 331344
US$ 25.06
US$ 28.10
US$ 28.55
US$ 26.52
US$ 21.85
